Reuters logo
BRIEF-Horizon Pharma provides update on PBM formulary status for primary care medicines
September 29, 2016 / 12:16 PM / a year ago

BRIEF-Horizon Pharma provides update on PBM formulary status for primary care medicines

Sept 29 (Reuters) - Horizon Pharma PLC :

* Horizon Pharma PLC provides update on PBM formulary status for primary care medicines

* Horizon Pharma - Co has entered into a rebate agreement with Prime Therapeutics, which secures formulary status for its primary care medicines

* Horizon Pharma - rebate agreement begins on October 1, 2016 Source text for Eikon: Further company coverage: ;))

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below